Metastatic Intracranial Malignant Neoplasm

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Metastatic Intracranial Malignant Neoplasm trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT05786924

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

BDTX-4933-101 is a first-in-human, open-label, Phase 1/2 dose escalation, dose optimization and expansion study designed to evaluate the safety and tolerability…

United States554 participantsStarted 2023-04-18

Treatment: S241656, FOLFOX6/FOLFOX7

All recent trials (16 shown)

Active — Not RecruitingPhase 2

NCT03175432

Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases

This phase II trial studies how well bevacizumab and atezolizumab with or without cobimetinib work in treating patients with untreated melanoma that has spread…

United States29 participantsStarted 2017-06-15

Treatment: Atezolizumab, Bevacizumab

TerminatedPhase 1/2

NCT04789668

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

This phase I/II trial studies the best dose and effect of pimasertib in combination with bintrafusp alfa in treating patients with cancer that has spread to the…

United States8 participantsStarted 2021-01-15

Treatment: Bintrafusp Alfa, Pimasertib

Metastatic Intracranial Malignant Neoplasm

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

All recent trials (16 shown)

Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

All recent trials (16 shown)

Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases

Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cel…

18F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the Brain

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation…

Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis

Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intra…

Stereotactic Radiosurgery in Treating Patients With Brain Tumors

DECT in Imaging Patients With Solid Organ Cancer With Intracranial Metastasis

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multipl…

Safety Study of 2DG With Stereotactic Radiosurgery

Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracrani…

Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain